Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

90 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Infliximab is a plausible alternative for neurologic complications of Behçet disease.
Zeydan B, Uygunoglu U, Saip S, Demirci ON, Seyahi E, Ugurlu S, Hamuryudan V, Siva A, Kantarci OH. Zeydan B, et al. Among authors: uygunoglu u. Neurol Neuroimmunol Neuroinflamm. 2016 Jul 8;3(5):e258. doi: 10.1212/NXI.0000000000000258. eCollection 2016 Oct. Neurol Neuroimmunol Neuroinflamm. 2016. PMID: 27458602 Free PMC article.
Myelopathy in Behçet's disease: The Bagel Sign.
Uygunoglu U, Zeydan B, Ozguler Y, Ugurlu S, Seyahi E, Kocer N, Islak C, Kantarci K, Saip S, Siva A, Kantarci OH. Uygunoglu U, et al. Ann Neurol. 2017 Aug;82(2):288-298. doi: 10.1002/ana.25004. Epub 2017 Aug 10. Ann Neurol. 2017. PMID: 28749553
Behçet's syndrome: providing integrated care.
Esatoglu SN, Kutlubay Z, Ucar D, Hatemi I, Uygunoglu U, Siva A, Hatemi G. Esatoglu SN, et al. Among authors: uygunoglu u. J Multidiscip Healthc. 2017 Aug 14;10:309-319. doi: 10.2147/JMDH.S93681. eCollection 2017. J Multidiscip Healthc. 2017. PMID: 28860798 Free PMC article. Review.
Biosimilar infliximab for Behçet's syndrome: a case series.
Dincses E, Esatoglu SN, Ozguler Y, Uygunoglu U, Hamuryudan V, Seyahi E, Melikoglu M, Fresko I, Ucar D, Ozyazgan Y, Kutlubay Z, Mat MC, Yurdakul S, Siva A, Hatemi G. Dincses E, et al. Among authors: uygunoglu u. Clin Exp Rheumatol. 2019 Nov-Dec;37 Suppl 121(6):111-115. Epub 2019 Dec 9. Clin Exp Rheumatol. 2019. PMID: 31856937 Free article.
Emergence of new manifestations during infliximab treatment in Behçet's syndrome.
Tukek NB, Esatoglu SN, Hatemi G, Calıskan EB, Ozyazgan Y, Ucar D, Ozguler Y, Seyahi E, Melikoglu M, Uygunoglu U, Siva A, Kutlubay Z, Hatemi İ, Celik AF, Ugurlu S, Fresko I, Yurdakul S, Yazici H, Hamuryudan V. Tukek NB, et al. Among authors: uygunoglu u. Rheumatology (Oxford). 2022 Aug 30;61(9):3746-3753. doi: 10.1093/rheumatology/keab944. Rheumatology (Oxford). 2022. PMID: 34958357
Safety of SARS-CoV-2 vaccination in patients with Behcet's syndrome and familial Mediterranean fever: a cross-sectional comparative study on the effects of M-RNA based and inactivated vaccine.
Ozdede A, Guner S, Ozcifci G, Yurttas B, Toker Dincer Z, Atli Z, Uygunoğlu U, Durmaz E, Uçar D, Uğurlu S, Saip S, Tabak F, Hamuryudan V, Seyahi E. Ozdede A, et al. Among authors: uygunoglu u. Rheumatol Int. 2022 Jun;42(6):973-987. doi: 10.1007/s00296-022-05119-y. Epub 2022 Apr 4. Rheumatol Int. 2022. PMID: 35376962 Free PMC article.
Behçet Syndrome.
Hatemi G, Uçar D, Uygunoğlu U, Yazici H, Yazici Y. Hatemi G, et al. Among authors: uygunoglu u. Rheum Dis Clin North Am. 2023 Aug;49(3):585-602. doi: 10.1016/j.rdc.2023.03.010. Epub 2023 May 2. Rheum Dis Clin North Am. 2023. PMID: 37331734 Review.
90 results